Mohamed Naguib, MD

Mohamed Naguib, MD
  • No ratings
  • 0 Patient Satisfaction Ratings
  • 0 Patient Comments

Mohamed Naguib, MD

Department General Anesthesiology
Primary Location Cleveland Clinic Main Campus
Type of Doctor Adults Only
Languages English
Surgeon No
Locations
Insurance

Insurance

Is Cleveland Clinic Part of Your Insurance?

Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.

View All Plans
Education & Professional Highlights

Education & Professional Highlights

Appointed
2010

Education & Fellowships

Fellowship - University of California-San Diego
Pain Research
La Jolla, CA USA
1992

Residency - Cairo University Hospital
Anesthesiology
Cairo, Egypt
1981

Internship - Cairo University Hospital
Medicine
Cairo, Egypt
1978

Medical School - Cairo University
Cairo, Egypt
1976

Additional Training

  • Post-Doctoral Research Fellow in the Department of Anesthesiology, University of California, San Diego, California

Professional Highlights

  • Professor of Anesthesiology, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University

Certifications

  • Royal College of Physicians of Ireland - Anesthesiology
  • Anesthesiology

Awards & Honors

  • Elmer Zsigmund Award from The International Society of Anaesthetic Pharmacology for the best Scientific contribution,  2008, 2012, 2013, and 2014. 
  • Innovation Award, Cleveland Clinic Innovation, 2013.<p>&nbsp;</p><p> </p>

Innovations & Patents

  • <ol><li><a shape="rect" href="http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&amp;Sect2=HITOFF&amp;u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&amp;r=8&amp;f=G&amp;l=50&amp;d=PTXT&amp;p=1&amp;S1=attala&amp;OS=attala&amp;RS=attala" target="_blank" shape="rect">The use of melatonin for induction of general anesthesia</a>. US Patent #6,552,064 dated April 22, 2003. Inventor: Mohamed Naguib Attala.
  • <a shape="rect" href="http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&amp;Sect2=HITOFF&amp;u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&amp;r=7&amp;f=G&amp;l=50&amp;d=PTXT&amp;p=1&amp;S1=attala&amp;OS=attala&amp;RS=attala" target="_blank" shape="rect">Use of melatonin analogues for induction of general anesthesia</a>. Patent No. US 6,638,966 dated October 28, 2003. Inventors: Max T. Baker, Mohamed Naguib Attala.
  • <a shape="rect" href="http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&amp;Sect2=HITOFF&amp;p=1&amp;u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&amp;r=1&amp;f=G&amp;l=50&amp;co1=AND&amp;d=PTXT&amp;s1=7,312,250&amp;OS=7,312,250&amp;RS=7,312,250" target="_blank" shape="rect">Fluorine-substituted alkyl phenol compounds and their uses</a>. US Patent No.: 7,312,250 B2 dated December 25, 2007. Inventors: Max T. Baker, Mohamed Naguib Attala.
  • <a shape="rect" href="http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&amp;Sect2=HITOFF&amp;u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&amp;r=1&amp;f=G&amp;l=50&amp;d=PTXT&amp;p=1&amp;S1=attala&amp;OS=attala&amp;RS=attala" target="_blank" shape="rect">Melatonin Analouge Prodrugs</a>. US Patent No. 7,381,740 B2 Dated June 3, 2008. Inventors: Max T. Baker, Mohamed Naguib Attala.
  • <a shape="rect" href=" http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&amp;Sect2=HITOFF&amp;p=1&amp;u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&amp;r=1&amp;f=G&amp;l=50&amp;co1=AND&amp;d=PG01&amp;s1=%2220040002536+A1%22&amp;OS=" target="_blank" shape="rect" &rs="20040002536+A1">Composition of melatonin for induction of general anesthesia</a>. US Patent Application No.20040002536 A1 Dated January 1, 2004. Inventor: Mohamed Naguib Attala.
  • <a shape="rect" href="http://www.wipo.int/pctdb/en/wo.jsp?WO=2009012221" target="_blank" shape="rect">(WO 2009/012221 HETEROCYCLIC MODULATORS OF CANNABINOID RECEPTORS</a>. Inventors: Mohamed Naguib and Philippe Diaz.
  • <a shape="rect" href="http://www.wipo.int/pctdb/en/wo.jsp?WO=2009012227" target="_blank" shape="rect">(WO 2009/012227) HYDRAZONE MODULATORS OF CANNABINOID RECEPTORS</a>. Inventors: Mohamed Naguib and Philippe Diaz. </li></ol>

Memberships

  • Editorial Board, <i>Anesthesia &amp; Analgesia</i>
  • Vice President, The International Society for Anaesthetic Pharmacology (ISAP), USA: <a shape="rect" href="http://www.isaponline.org/about/board/" shape="rect">http://www.isaponline.org/about/board/</a>
  • Chairman of the “Moderate Sedation Training Oversight Committee”-The International Society for Anaesthetic Pharmacology (ISAP), 2013- present.
Research & Publications

Research & Publications

See publications for Mohamed Naguib, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 4/27/2016, Dr. Naguib has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Royalty Payments. Dr. Naguib receives or has the right to receive royalty payments for inventions or discoveries commercialized through the companies shown below:

  • NeuroTherpia, Inc.

Right to Future Distribution of Cleveland Clinic Financial Interest. Dr. Naguib may receive future financial benefits from the Cleveland Clinic for inventions or discoveries commercialized through the companies shown below:

  • NeuroTherpia, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Related Videos